Earnings Call · Q2 FY2026·2026-07-31

Q2 26EPS +0.27%·Rev n/aQ1 26EPS -0.75%·Rev n/aQ4 25EPS +2.26%·Rev n/aQ3 25EPS +4.49%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Senior Vice President, Investor Relations

Rob Michael — Chairman and Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Roopal Thakkar — Executive Vice President, Research and Development, Chief Scientific Officer

Scott Reents — Executive Vice President, Chief Financial Officer

−2.5%1d on move date3d−5.3%5d−5.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access